Agendia

Agendia BV is a genomic pharmacology research company founded in 2003 by researchers from the Dutch Cancer Research Centre (Nederlands Kanker Instituut). Agendia has established the first test for diagnosing the aggressive character of breast tumours on the basis of the activity of determining genes.